Will The Rally In Cassava Sciences Stock Continue After A Large 66% Rise In A Month?Forbes • 06/22/21
Cassava Sciences Selects Clinical Research Organization for Phase 3 Clinical Program in Alzheimer's DiseaseGlobeNewsWire • 06/21/21
Cassava Sciences Stock Gains After Outlining Clinical Development Progress For Lead Alzheimer's CandidateBenzinga • 06/21/21
Cassava Sciences Provides Mid-Year Corporate Update, Clinical Development Progress and Announces Guidance on Clinical Data ReleaseGlobeNewsWire • 06/21/21
Cassava Sciences to Present at the Raymond James 2021 Human Health Innovation ConferenceGlobeNewsWire • 06/17/21
Cassava Sciences Announces the Appointment of Richard J. Barry to its Board of DirectorsGlobeNewsWire • 06/14/21
Ignore Biogen: 3 Reasons These Stocks Will Be Better Alzheimer's InvestmentsThe Motley Fool • 06/11/21
Healthcare And Biotech Stocks Face Important Decisions, Remain A Promising InvestmentSeeking Alpha • 06/02/21